MYCN and neuroblastoma: Further analysis of mRNA levels upon CYC065 treatment across a panel of MYCN-amplified NB cell lines as well as tumors from the MYCN-driven TH-MYCN mouse model revealed a selective depletion of Myc target gene expression (Figure 3I and Supplemental Figure 6E).